Literature DB >> 19520388

Environmental changes and epidemiology of multiple sclerosis in the French West Indies.

Philippe Cabre1.   

Abstract

Multiple sclerosis (MS) emerged in the French West Indies (Martinique and Guadeloupe) at the beginning of the 1990s with an incidence for the period 1992-2007 of 1.27/100,000 (95% CI, 1.16-1.38). Its incidence, which is continuously increasing, reached 2.27/100,000 (95% CI, 1.92-2.62) in Martinique for the period 2002-07. Neuromyelitis optica (NMO), in contrast, has a stable incidence of 0.19/100,000 (95% CI, 0.15-0.23) resulting in a gradual increase in the MS/NMO ratio, which was 8.35 for the period 2002-07. MS initially affected the female population with a female/male incidence ratio of 8.43 for the period 1992-97, which gradually fell to 2.63 for the period 2002-07 due to the increased incidence of MS in men. Several environmental factors are involved in the emergence of MS: (1) the migration of the French West Indian population to mainland France resulted in an excess incidence of MS in the migrants; (2) a decrease in sun exposure, a risk factor for MS, related to the changing lifestyle of the French West Indian population has been demonstrated in a case-control study; (3) at ecological level, enhanced hygiene associated with the eradication of intestinal helminthiases, known to induce immune system tolerance, is also strongly suspected with regard to MS emergence.

Entities:  

Mesh:

Year:  2009        PMID: 19520388     DOI: 10.1016/j.jns.2009.04.039

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  16 in total

Review 1.  Regulation of the immune system by biodiversity from the natural environment: an ecosystem service essential to health.

Authors:  Graham A Rook
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-23       Impact factor: 11.205

2.  The incidence and prevalence of neuromyelitis optica: a systematic review.

Authors:  Ruth Ann Marrie; Caroline Gryba
Journal:  Int J MS Care       Date:  2013

3.  Practice current: How do you treat neuromyelitis optica?

Authors:  Aravind Ganesh
Journal:  Neurol Clin Pract       Date:  2017-04

4.  No association between identified multiple sclerosis non-MHC risk loci and neuromyelitis optica.

Authors:  Qi-Bing Liu; Zhen-Xin Li; Gui-Xian Zhao; Hai Yu; Zhi-Ying Wu
Journal:  Neurosci Bull       Date:  2014-06-13       Impact factor: 5.203

Review 5.  Inflammatory Optic Neuritis: From Multiple Sclerosis to Neuromyelitis Optica.

Authors:  Jérôme de Seze
Journal:  Neuroophthalmology       Date:  2013-07-25

Review 6.  Optic neuritis.

Authors:  D Pau; N Al Zubidi; S Yalamanchili; G T Plant; A G Lee
Journal:  Eye (Lond)       Date:  2011-04-29       Impact factor: 3.775

7.  Familial neuromyelitis optica.

Authors:  M Matiello; H J Kim; W Kim; D G Brum; A A Barreira; D J Kingsbury; G T Plant; T Adoni; B G Weinshenker
Journal:  Neurology       Date:  2010-07-27       Impact factor: 9.910

8.  Assessment of Patients with Neuromyelitis Optica Spectrum Disorder Using the EQ-5D.

Authors:  Maureen A Mealy; Audra Boscoe; Jaime Caro; Michael Levy
Journal:  Int J MS Care       Date:  2019 May-Jun

9.  Incidence of multiple sclerosis among European Economic Area populations, 1985-2009: the framework for monitoring.

Authors:  Enrique Alcalde-Cabero; Javier Almazán-Isla; Antonio García-Merino; Joao de Sá; Jesús de Pedro-Cuesta
Journal:  BMC Neurol       Date:  2013-06-12       Impact factor: 2.474

10.  New insights into neuromyelitis optica.

Authors:  Woojun Kim; Su-Hyun Kim; Ho Jin Kim
Journal:  J Clin Neurol       Date:  2011-09-29       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.